Triphenylphosphine → (2R)-N,N-dimethyl-2-[(4-oxo-3,4-dihydroquinazolin-5-yl)oxy]propanamide
반응식
C(OC[N:9]1[C:18](=[O:19])[C:17]2[C:12](=[CH:13][CH:14]=[CH:15][C:16]=2[OH:20])[N:11]=[CH:10]1)(=O)C(C)(C)C.C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.[CH3:40][N:41]([CH3:47])[C:42](=[O:46])[C@H:43]([CH3:45])O>C(Cl)Cl>[CH3:40][N:41]([CH3:47])[C:42](=[O:46])[C@H:43]([O:20][C:16]1[CH:15]=[CH:14][CH:13]=[C:12]2[C:17]=1[C:18](=[O:19])[NH:9][CH:10]=[N:11]2)[CH3:45]참가 물질
실험 절차
DTAD (13.34 g, 58 mmol) was added portion-wise to an ice-cooled solution of (5-hydroxy-4-oxoquinazolin-3(4H)-yl)methyl pivalate (8 g, 29 mmol), triphenylphosphine (15.2 g, 58 mmol) and (S)—N,N-dimethyl lactamide (5.1 g, 43.5 mmol; obtained as described in Larcheveque M., Synthesis 1986, 1, 60) in DCM (300 ml). The mixture was stirred at room temperature for one hour. After evaporation of the solvents under vacuum, the residue was diluted with 6N methanolic ammonia (100 ml). The mixture was stirred at room temperature for 18 hours. After evaporation of the solvents, the residue was triturated in ether. The resulting solid was filtered and purified further by chromatography on silica gel (eluant: 3 to 5% methanol in DCM) to give (2R)—N,N-dimethyl-2-[(4-oxo-3,4-dihydroquinazolin-5-yl)oxy]propanamide as a white solid (5.4 g, 71%); NMR Spectrum (CDCl3) 1.77 (d, 3H), 2.94 (s, 3H), 3.19 (s, 3H), 5.10 (q, 1H), 6.92 (d, 1H), 7.35 (d, 1H), 7.63 (t, 1H), 8.00 (s, 1H); Mass spectrum MH+ 262.
후처리
- customAfter evaporation of the solvents under vacuum
- additionthe residue was diluted with 6N methanolic ammonia (100 ml)
- stirringThe mixture was stirred at room temperature for 18 hours
- customAfter evaporation of the solvents
- customthe residue was triturated in ether
- filtrationThe resulting solid was filtered
- custompurified further by chromatography on silica gel (eluant: 3 to 5% methanol in DCM)
출처 및 근거
- ORD 기록
- ord-a8eac9c1249849388ce7441a3e6b4d60
- 출처 데이터셋
- uspto-grants-2010_10
- 특허 번호
- US07820683B2
반응 노트
불러오는 중…